A Phase IIa Study of Subcutaneous AER 001 on Antigen Challenge In Atopic Asthmatic Subjects (28 Day Study)

Clinical trial NCT00535028 · COMPLETED

Trial details

NCT number: NCT00535028
Sponsor: Aerovance, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Allergic Asthma

Start date: 2005-01-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.